(
NASDAQ
:
INO
)
Inovio Pharmaceuticals
's forecast annual earnings growth rate of
N/A
is
not
forecast to beat the
US
Biotechnology
industry's average forecast earnings growth rate of
15.32%
, and
while it is
not
forecast to beat the
US
market's average forecast earnings growth rate of
17.02%
.
Inovio Pharmaceuticals
's earnings in
2024
is
-$121,640,471
.
On average, 4 Wall Street analysts forecast INO's earnings for 2024 to be -$117,942,687, with the lowest INO earnings forecast at -$129,042,412, and the highest INO earnings forecast at -$103,597,429. On average, 4 Wall Street analysts forecast INO's earnings for 2025 to be -$91,653,866, with the lowest INO earnings forecast at -$104,895,643, and the highest INO earnings forecast at -$75,556,020.
In 2026, INO is forecast to generate $18,694,273 in earnings, with the lowest earnings forecast at -$45,956,754 and the highest earnings forecast at $83,345,300.
